Application of two dimensional electrophoresis and immunohistochemistry for detection of protein deglycase DJ-1 overexpression in canine lymphoma
Publication date: January 2019Source: Journal of Comparative Pathology, Volume 166Author(s): A. Kycko, M. Reichert, W. Łopuszyński, A. Śmiech
Publication date: Available online 17 July 2019Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Fernando Cabanillas, Noridza Rivera, Mirelis Acosta, Wandaly Pardo, Pedro Solivan, Caroline Rivera, Idalia LiboyAbstractBackgroundOur objective was to evaluate the impact of lenalidomide in patients with aggressive lymphoma who attained
(Northwestern University) Many of the deadliest or most common cancers get the least amount of nonprofit research funding, reports a new Northwestern Medicine study. 'Embarrassing' or stigmatized cancers, like lung and liver, are underfunded. Colon, endometrial, liver and bile duct, cervical, ovarian, pancreatic and lung cancers were all poorly funded compared to how common they are and how many deaths they cause, the study found. In contrast, breast cancer, leukemia, lymphoma and pediatric cancers were all well-funded, respective to their impact on society.
Lymphoma - What is the role of diagnostic testing cytogenetics in 2016 Author: cancergrace Added: 07/17/2019
Author: cancergrace Added: 07/17/2019
Authors: Abstract [This corrects the article on p. 3 in vol. 54, PMID: 30956955.]. PMID: 31309098 [PubMed - in process]
Authors: Eskandari M, Manoochehrabadi S, Pashaiefar H, Zaimy MA, Ahmadvand M Abstract Background: Cell-free DNA (cfDNA) has the potential to serve as a non-invasive prognostic biomarker in some types of neoplasia. The investigation of plasma concentration of cfDNA may reveal its use as a valuable biomarker for risk stratification of diffuse large B-cell lymphoma (DLBCL). The present prognostic value of plasma cfDNA has not been widely confirmed in DLBCL subjects. Here, we evaluated cfDNA plasma concentration and assessed its potential prognostic value as an early DLBCL diagnostic tool. Methods: cfDNA concentrat...
Conclusion: Our study showed that bendamustine is a potentially toxic agent in the conditioning regimen for autologous SCT, resulting in significant liver, kidney, and gastrointestinal toxicity. Further studies are required to assess its safety and efficacy at reduced doses. PMID: 31309088 [PubMed]
This study aimed to investigate the transcript dynamics of PLK1 and determine its role in the pathophysiology of MDS. Methods: PLK1 mRNA obtained from the bone marrow samples of 67 patients with MDS, 16 patients with secondary acute myeloid leukemia (sAML), and 10 healthy controls were analyzed using quantitative real-time PCR and compared according to various clinical parameters. Results: The median PLK1 expression levels differed slightly, but not significantly, between MDS and sAML patients [661.21 (range, 29.38-8,987.31) vs. 1,462.05 (32.22-5,734.09), respectively], but were significantly higher (P
Authors: Sung YN, Huh J PMID: 31309083 [PubMed]